Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 261 Projects
Project # Contact PI Funding Organization Fiscal Year
Discovery of selective LRP1 inhibitors to prevent tau uptake and spread
ADDF-57 Kosik, Kenneth Alzheimer's Drug Discovery Foundation 2022
FINGERS Brain Health Institute
ADDF-59 Kivipelto, Miia Alzheimer's Drug Discovery Foundation 2022
Can Lifestyle Changes Stop or Reverse the Progression of MCI Due to Early-Stage Alzheimer's Disease?
ADDF-37 Ornish, Dean Alzheimer's Drug Discovery Foundation 2021
Effects of Chaperone-Mediated Autophagy in Alzheimer's Disease
ADDF-39 Cermak, Jennifer Alzheimer's Drug Discovery Foundation 2021
MIB-626 For Treatment of Mild Dementia Patients
ADDF-43 Livingston, David Alzheimer's Drug Discovery Foundation 2021
Testing low-dose efavirenz treatment for Alzheimer’s disease: a phase 1b dosing, target-engagement and exploratory biomarker study.
ADDF-48 SCHELTENS, PHILIP Alzheimer's Drug Discovery Foundation 2021
Preserving NPTX2 and Memory in Alzheimer's Disease
ADDF-49 Worley, Paul Alzheimer's Drug Discovery Foundation 2021
A single-center, randomized, placebo-controlled single & multiple ascending dose study in healthy subjects to study the safety, tolerability, food effect, pharmacokinetics and target engagement of the second-generation O-GlcNAcase inhibitor ASN121151
ADDF-1 Beher, Dirk Alzheimer's Drug Discovery Foundation 2020
A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform
ADDF-13 Ballard, Clive Alzheimer's Drug Discovery Foundation 2020
MET-FINGER-APOE: A randomized controlled trial of multimodal lifestyle intervention and metformin to prevent cognitive impairment and disability in a cognitively healthy APOE4 enriched at-risk population
ADDF-14 Kivipelto, Miia Alzheimer's Drug Discovery Foundation 2020